These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 165942)

  • 41. Human mammary cancer cell mutants with altered hormone receptor activity.
    Ueda H; Hagino Y; Ono M; Kuwano M
    J Biochem; 1986 Aug; 100(2):341-8. PubMed ID: 3023306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of tamoxifen in relation to breast cancer.
    Jordan VC
    Br Med J; 1977 Jun; 1(6075):1534-5. PubMed ID: 871651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to an antiestrogen.
    Mortel R; Levy C; Wolff JP; Nicolas JC; Robel P; Baulieu EE
    Cancer Res; 1981 Mar; 41(3):1140-7. PubMed ID: 6936073
    [No Abstract]   [Full Text] [Related]  

  • 44. Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor.
    Connor CE; Norris JD; Broadwater G; Willson TM; Gottardis MM; Dewhirst MW; McDonnell DP
    Cancer Res; 2001 Apr; 61(7):2917-22. PubMed ID: 11306468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.
    Robertson JF; Nicholson RI; Bundred NJ; Anderson E; Rayter Z; Dowsett M; Fox JN; Gee JM; Webster A; Wakeling AE; Morris C; Dixon M
    Cancer Res; 2001 Sep; 61(18):6739-46. PubMed ID: 11559545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific progesterone receptors in human breast cancer.
    Horwitz KB; McGuire WL
    Steroids; 1975 Apr; 25(4):497-505. PubMed ID: 165596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estradiol receptors in benign and malignant disease of the breast.
    Leung BS; Manaugh LC; Wood DC
    Clin Chim Acta; 1973 Jun; 46(1):69-76. PubMed ID: 4354612
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata.
    Jordan VC
    Eur J Cancer (1965); 1976 Jun; 12(6):419-24. PubMed ID: 821733
    [No Abstract]   [Full Text] [Related]  

  • 49. Proceedings: The effect of tamoxifen (ici) 46, 474) on ovarian oestrogen synthesis in the early pregnant rat.
    Watson J; Alam M
    J Endocrinol; 1975 Jul; 66(1):2P. PubMed ID: 1172517
    [No Abstract]   [Full Text] [Related]  

  • 50. Roles of antiestrogen binding sites in human endometrial cancer cells.
    Hayashida M; Terakawa N; Shimizu I; Ikegami H; Wakimoto H; Aono T; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1987 Jun; 26(6):705-11. PubMed ID: 3613570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro.
    Paulsen GH; Strickert T; Marthinsen AB; Lundgren S
    Acta Oncol; 1996; 35(8):1011-9. PubMed ID: 9023387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Female sex steroid receptors in post menopausal endometrial carcinoma. Biochemical responses to antiestrogen and progestin.
    Robel P; Gravanis A; Roger-Jallais L; Catelli MG; Binart N; George M; Laval C; Baulieu EE
    Prog Clin Biol Res; 1984; 142():167-79. PubMed ID: 6709656
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma hormones and pituitary luteinizing hormone in the rat during the early stages of pregnancy and after post-coital treatment with tamoxifen (ICI 46,474).
    Watson J; Anderson FB; Alam M; O'Grady JE; Heald PJ
    J Endocrinol; 1975 Apr; 65(1):7-17. PubMed ID: 1141814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The combined effect of nonsteroidal anti-oestrogens and sex steroids on the growth of rat uterine adenocarcinoma cells in tissue culture.
    Sekiya S; Takamizawa H
    Br J Obstet Gynaecol; 1976 Mar; 83(3):183-6. PubMed ID: 943174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tamoxifen-stimulated growth of human endometrial carcinoma.
    Jordan VC; Gottardis MM; Satyaswaroop PG
    Ann N Y Acad Sci; 1991; 622():439-46. PubMed ID: 1905895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of Nolvadex (tamoxifen citrate; ICI 46,474) on pregnancy in rabbits.
    Furr BJ; Valcaccia B; Challis JR
    J Reprod Fertil; 1976 Nov; 48(2):367-9. PubMed ID: 994109
    [No Abstract]   [Full Text] [Related]  

  • 58. Specific estrogen binding in vivo in the R3230AC mammary adenocarcinoma of the rat.
    Boylan ES; Wittliff JL
    Cancer Res; 1973 Nov; 33(11):2903-8. PubMed ID: 4355983
    [No Abstract]   [Full Text] [Related]  

  • 59. Interaction of spironolactone with oestradiol receptors in cytosol.
    Levy J; Burshell A; Marbach M; Afllalo L; Glick SM
    J Endocrinol; 1980 Mar; 84(3):371-9. PubMed ID: 7391714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiestrogenic and antitumor properties of tamoxifen in laboratory animals.
    Jordan VC
    Cancer Treat Rep; 1976 Oct; 60(10):1409-19. PubMed ID: 828517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.